iBio, Inc. (IBIO)
NASDAQ: IBIO · Real-Time Price · USD
1.180
-0.020 (-1.67%)
Sep 15, 2026, 4:00 PM EDT - Market closed
iBio, Inc. Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 56.4 | 8.58 | 14.21 | 4.3 | 22.68 |
Short-Term Investments | 31.64 | - | - | - | 10.85 |
Cash & Short-Term Investments | 88.04 | 8.58 | 14.21 | 4.3 | 33.52 |
Cash Growth | 925.86% | -39.61% | 230.39% | -87.17% | -65.43% |
Accounts Receivable | - | - | - | - | 1 |
Other Receivables | - | 0.11 | - | 0.2 | - |
Receivables | 1.1 | 0.11 | 0.71 | 0.2 | 1 |
Prepaid Expenses | 3.08 | 1.03 | 0.75 | 0.66 | 1.55 |
Restricted Cash | - | - | - | 3.03 | - |
Other Current Assets | - | - | - | 18.07 | 9 |
Total Current Assets | 92.22 | 9.72 | 15.67 | 26.26 | 45.07 |
Property, Plant & Equipment | 4.75 | 5.28 | 6.37 | 7.55 | 4.44 |
Other Intangible Assets | 1.83 | 6.85 | 5.37 | 5.39 | 4.85 |
Other Long-Term Assets | 0.31 | 0.24 | 0.24 | 0.3 | 43.41 |
Total Assets | 99.11 | 23.19 | 28.73 | 41.21 | 99.41 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 4.42 | 2.19 | 0.36 | 1.85 | 4.26 |
Accrued Expenses | 5.63 | 1.35 | 2.03 | 4.56 | 3.76 |
Short-Term Debt | - | - | 0.12 | 12.94 | 22.16 |
Current Portion of Long-Term Debt | - | 0.77 | 0.22 | - | - |
Current Portion of Leases | 0.55 | 0.61 | 0.91 | 0.82 | 0.09 |
Current Unearned Revenue | 1.15 | 1.2 | 0.2 | - | 0.1 |
Other Current Liabilities | - | - | - | 1.94 | 0.06 |
Total Current Liabilities | 11.75 | 6.11 | 3.84 | 22.11 | 30.44 |
Long-Term Debt | - | - | 0.77 | - | - |
Long-Term Leases | 1.65 | 2.2 | 2.8 | 3.72 | 3.51 |
Other Long-Term Liabilities | - | - | - | - | 1.97 |
Total Liabilities | 13.4 | 8.31 | 7.41 | 25.83 | 35.92 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0.06 | 0.02 | 0.01 | 0 | 0.01 |
Additional Paid-In Capital | 450.97 | 347.09 | 335.16 | 304.32 | 287.62 |
Retained Earnings | -365.27 | -332.22 | -313.85 | -288.94 | -223.93 |
Comprehensive Income & Other | -0.05 | - | - | - | -0.21 |
Total Common Equity | 85.71 | 14.88 | 21.32 | 15.38 | 63.49 |
Shareholders' Equity | 85.71 | 14.88 | 21.32 | 15.38 | 63.49 |
Total Liabilities & Equity | 99.11 | 23.19 | 28.73 | 41.21 | 99.41 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 2.2 | 3.57 | 4.82 | 17.48 | 25.77 |
Net Cash (Debt) | 85.84 | 5.01 | 9.39 | -13.17 | 7.76 |
Net Cash Growth | 1613.39% | -46.62% | - | - | -87.93% |
Net Cash Per Share | 0.82 | 0.48 | 2.45 | -21.53 | 17.78 |
Filing Date Shares Outstanding | 64.31 | 19.65 | 8.64 | 1.38 | 0.45 |
Total Common Shares Outstanding | 55.7 | 19.35 | 8.62 | 1.02 | 0.44 |
Working Capital | 80.48 | 3.62 | 11.83 | 4.15 | 14.63 |
Book Value Per Share | 1.54 | 0.77 | 2.47 | 15.15 | 145.49 |
Tangible Book Value | 83.89 | 8.03 | 15.96 | 9.99 | 58.63 |
Tangible Book Value Per Share | 1.51 | 0.42 | 1.85 | 9.84 | 134.37 |
Buildings | 0.7 | 0.7 | 0.7 | 0.7 | - |
Machinery | 4.42 | 3.96 | 3.95 | 3.92 | - |
Construction In Progress | 0.02 | - | - | - | 1.37 |